Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

about

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

Item

http://www.wikidata.org/entity/Q37098376

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children

@en

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children.

@nl

type

Item

label

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children

@en

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children.

@nl

prefLabel

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children

@en

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children.

@nl

P1476

Plasma pharmacokinetics of onc ...... in HIV-infected Thai children

@en

P2093

Amornrat Srimuan

http://www.w3.org/2001/XMLSchema#string

Chulalak Sriheara

http://www.w3.org/2001/XMLSchema#string

David M Burger

http://www.w3.org/2001/XMLSchema#string

Jiratchaya Sophonphan

http://www.w3.org/2001/XMLSchema#string

Narukjaporn Thammajaruk

http://www.w3.org/2001/XMLSchema#string

Passorn Punyahotra

http://www.w3.org/2001/XMLSchema#string

Thanyawee Puthanakit

http://www.w3.org/2001/XMLSchema#string

Tim R Cressey

http://www.w3.org/2001/XMLSchema#string

Torsak Bunupuradah

http://www.w3.org/2001/XMLSchema#string

P2860

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis

A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.

A review of the pharmacokinetics of abacavir.

Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.

Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months.

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.

P304

185-191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jintanat Ananworanich

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27482411

http://www.w3.org/2001/XMLSchema#string

P921

An Téalainn

P932

4946738

http://www.w3.org/2001/XMLSchema#string